1. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87(2):489-99.

2. Bahemuka, M. and H. M. Hodkinson (1975). "Screening for hypothyroidism in elderly inpatients." Br Med J 2(5971): 601-3.

3. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977 Dec;7(6):481-93.

4. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med. 1985 Aug;145(8):1386-8.

5. Brochmann H, Bjoro T, Gaarder PI, Hanson F, Frey HM. Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community (Naeroy). Acta Endocrinol (Copenh). 1988 Jan;117(1):7-12.

6. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med. 1990 Apr;150(4):785-7.

7. Luboshitzky R, Oberman AS, Kaufman N, Reichman N, Flatau E. Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. Isr J Med Sci. 1996 Jan;32(1):60-5.

8. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160(4):526-34.

9. Bemben DA, Winn P, Hamm RM, Morgan L, Davis A, Barton E. Thyroid disease in the elderly. Part 1. Prevalence of undiagnosed hypothyroidism. J Fam Pract. 1994 Jun;38(6):577-82.

10. Drinka PJ, Nolten WE. Prevalence of previously undiagnosed hypothyroidism in residents of a midwestern nursing home. South Med J. 1990 Nov;83(11):1259-61, 1265. Erratum in: South Med J 1991 Jul;84(7):936.

11. Muller GM, Levitt NS, Louw SJ. Thyroid dysfunction in the elderly. S Afr Med J. 1997 Sep;87(9):1119-23.

12. Sawin CT, Geller A, Hershman JM, Castelli W, Bacharach P. The aging thyroid. The use of thyroid hormone in older persons. JAMA. 1989 May 12;261(18):2653-5.

13. Kung AW, Janus ED. Thyroid dysfunction in ambulatory elderly Chinese subjects in an area of borderline iodine intake. Thyroid. 1996 Apr;6(2):111-4.

14. Szabolcs I, Podoba J, Feldkamp J, Dohan O, Farkas I, Sajgo M, Takats KI, Goth M, Kovacs L, Kressinszky K, Hnilica P, Szilagyi G. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clin Endocrinol (Oxf). 1997 Jul;47(1):87-92.

15. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996;335(2):99-107.

16. Mariotti S, Chiovato L, Franceschi C, Pinchera A. Thyroid autoimmunity and aging. Exp Gerontol. 1998;33(6):535-41.

17. Pinchera A, Mariotti S, Barbesino G, et al. Thyroid autoimmunity and ageing. Horm Res. 1995;43(1-3):64-8.

18. Diez JJ. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy. J Gerontol A Biol Sci Med Sci. 2002 May;57(5):M315-20.

19. Blahos J, Soumar J. The role of age in the development of hypothyroidism after treatment with radoiodine. Endokrinologie. 1975 Jan;64(2):196-200.

20. Holm LE. Changing annual incidence of hypothyroidism after iodine-131 therapy for hyperthyroidism, 1951-1975. J Nucl Med. 1982 Feb;23(2):108-12.

21. Sridama V, McCormick M, Kaplan EL, Fauchet R, DeGroot LJ. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease. N Engl J Med. 1984 Aug 16;311(7):426-32. 22. Max MH, Scherm M, Bland KI. Early and late complications after thyroid operations. South Med J. 1983 Aug;76(8):977-80.

23. Tell R, Sjodin H, Lundell G, Lewin F, Lewensohn R. Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):303-8.

24. Gambert SR. Atypical presentation of thyroid disease in the elderly. Geriatrics. 1985;40(2):63-5, 68-9.

25. Rai GS, Gluck T, Luttrell S. Clinical presentation of hypothyroidism in older persons. J Am Geriatr Soc. 1995;43(5):592-3.

26. Robuschi G, Safran M, Braverman LE, Gnudi A, Roti E. Hypothyroidism in the elderly. Endocr Rev. 1987;8(2):142-53.

27. Isley WL. Thyroid dysfunction in the severely ill and elderly. Forget the classic signs and symptoms. Postgrad Med. 1993;94(3):111-8, 127-8.

28. Doucet J, Trivalle C, Chassagne P, Perol MB, Vuillermet P, Manchon ND, Menard JF, Bercoff E. Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc. 1994 Sep;42(9):984-6.

29. Mokshagundam S, Barzel US. Thyroid disease in the elderly. J Am Geriatr Soc. 1993;41(12):1361-9.

30. Tachman ML, Guthrie GP, Jr. Hypothyroidism: diversity of presentation. Endocr Rev. 1984;5(3):456-65.

31. Bonnyns, M., L. Vanhaelst, et al. (1982). "Asymptomatic atrophic thyroiditis." Horm Res 16(5): 338-44.

32. Osterweil D, Syndulko K, Cohen SN, Pettler-Jennings PD, Hershman JM,Cummings JL, Tourtellotte WW, Solomon DH. Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc. 1992 Apr;40(4):325-35.

33. Montenegro J, Gonzalez O, Saracho R, Aguirre R, Gonzalez O, Martinez I. Changes in renal function in primary hypothyroidism. Am J Kidney Dis. 1996 Feb;27(2):195-8.

34. Kabadi UM, Kumar SP. Pericardial effusion in primary hypothyroidism.Am Heart J. 1990 Dec;120(6 Pt 1):1393-5.

35. Ladenson PW, Levin AA, Ridgway EC, Daniels GH. Complications of surgery in hypothyroid patients. Am J Med. 1984 Aug;77(2):261-6.

36. Felicetta JV. Thyroid changes with aging: significance and management. Geriatrics. 1987;42(1):86-8, 91-2.

37. Lipson A, Nickoloff EL, Hsu TH, Kasecamp WR, Drew HM, Shakir R, Wagner HN Jr. A study of age-dependent changes in thyroid function tests in adults. J Nucl Med. 1979 Nov;20(11):1124-30.

38. Hansen JM, Skovsted L, Siersbaek-Nielsen K. Age dependent changes in iodine metabolism and thyroid function. Acta Endocrinol (Copenh). 1975 May;79(1):60-5. 39. Hershman JM, Pekary AE, Berg L, Solomon DH, Sawin CT. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged

euthyroid persons. J Am Geriatr Soc. 1993 Aug;41(8):823-8.

40. Olsen T, Laurberg P, Weeke J. Low serum triiodothyronine and high serum reverse triiodothyronine in old age: an effect of disease not age. J Clin Endocrinol Metab. 1978 Nov;47(5):1111-5.

41. Herrmann J, Heinen E, Kroll HJ, Rudorff KH, Kruskemper HL. Thyroid function and thyroid hormone metabolism in elderly people. Low T3-syndrome in old age? Klin Wochenschr. 1981 Apr 1;59(7):315-23.

42. Kabadi UM, Rosman PM. Thyroid hormone indices in adult healthy subjects: no influence of aging. J Am Geriatr Soc. 1988 Apr;36(4):312-6.

43. Barreca T, Franceschini R, Messina V, Bottaro L, Rolandi E. 24-hour thyroid-stimulating hormone secretory pattern in elderly men. Gerontology. 1985;31(2):119-23.

44. Targum SD, Marshall LE, Magac-Harris K, Martin D. TRH tests in a healthy elderly population. Demonstration of gender differences. J Am Geriatr Soc. 1989 Jun;37(6):533-6.

45. van Coevorden A, Laurent E, Decoster C, Kerkhofs M, Neve P, van Cauter E, Mockel J. Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab. 1989 Jul;69(1):177-85.

46. Ryan N, Kovacs K, Ezrin C. Thyrotrophs in old age. An immunocytologic study of human pituitary glands. Endokrinologie. 1979 Apr;73(2):191-8.

47. Nishikawa M, Inada M, Naito K, Ishii H, Tanaka K, Mashio Y, Imura H. Age-related changes of serum 3,3'-diiodothyronine, 3',5'-diiodothyronine, and 3,5-diiodothyronine concentrations in man. J Clin Endocrinol Metab. 1981 Mar;52(3):517-22.

48. Olivieri O, Girelli D, Azzini M, Stanzial AM, Russo C, Ferroni M, Corrocher R. Low selenium status in the elderly influences thyroid hormones. Clin Sci (Lond). 1995 Dec;89(6):637-42.

49. Takats IK, Peter F, Rimanoczi E, et al. The blood spot thyrotropin method is not adequate to screen for hypothyroidism in the elderly living in abundant-iodine intake areas: comparison to sensitive thyrotropin measurements. Thyroid. 2000;10(1):79-85.

50. Wiener R, Utiger RD, Lew R, Emerson CH. Age, sex, and serum thyrotropin concentrations in primary hypothyroidism. Acta Endocrinol (Copenh). 1991 Apr;124(4):364-9.

51. Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf). 1993;39(5):499-518.

52. Burman KD, Wartofsky L. Thyroid function in the intensive care unit setting. Crit Care Clin. 2001;17(1):43-57.

53. Wehmann RE, Gregerman RI, Burns WH, Saral R, Santos GW. Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med. 1985;312(9):546-52.

54. Burrows AW, Shakespear RA, Hesch RD, Cooper E, Aickin CM, Burke CW. Thyroid hormones in the elderly sick: "T4 euthyroidism". Br Med J. 1975 Nov 22;4(5994):437-9.

55. Simons RJ, Simon JM, Demers LM, Santen RJ. Thyroid dysfunction in elderly hospitalized patients. Effect of age and severity of illness. Arch Intern Med. 1990 Jun;150(6):1249-53.

56. Slag MF, Morley JE, Elson MK, Crowson TW, Nuttall FQ, Shafer RB. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA. 1981 Jan 2;245(1):43-5.

57. Surks MI, Hupart KH, Pan C, Shapiro LE. Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis. J Clin Endocrinol Metab. 1988 Nov;67(5):1031-9.

58. DeGroot LJ. "Non-thyroidal illness syndrome" is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge. J Endocrinol Invest 2003;26(12):1163-70.

59. Stathatos N, Wartofsky L. The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment? J Endocrinol Invest 2003;26(12):1174-9.

60. Hamblin PS, Dyer SA, Mohr VS, et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab. 1986;62(4):717-22.

61. Langton JE, Brent GA. Nonthyroidal illness syndrome: evaluation of thyroid function in sick patients. Endocrinol Metab Clin North Am. 2002;31(1):159-72.

62. Wong ET, Bradley SG, Schultz AL. Elevations of thyroid-stimulating hormone during acute nonthyroidal illness. Arch Intern Med. 1981 Jun;141(7):873-5.

63. Sawin CT, Bigos ST, Land S, Bacharach P. The aging thyroid. Relationship between elevated serum thyrotropin level and thyroid antibodies in elderly patients. Am J Med. 1985 Nov;79(5):591-5.

64. Drinka PJ, Nolten WE, Voeks S, Langer E. Thyroid stimulating hormone elevation without antithyroid antibody elevation in nursing home patients. J Am Geriatr Soc. 1991 Oct;39(10):1000-1.

65. Roti E, Gardini E, Minelli R, Bianconi L, Braverman LE. Prevalence of anti-thyroid peroxidase antibodies in serum in the elderly: comparison with other tests for anti-thyroid antibodies. Clin Chem. 1992 Jan;38(1):88-92.

66. Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA. 1987 Jul 10;258(2):209-13.

67. Vaamonde CA, Michael UF, Oster JR, et al. Impaired renal concentrating ability in hypothyroid man. Nephron. 1976;17(5):382-95.

68. Walton KW, Scott PJ, Dykes PW, Davies JW. The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131-I-low-density lipoproteins in hypothyroidism and thyrotoxicosis. Clin Sci. 1965;29(2):217-38.

69. Mastaglia FL, Ojeda VJ, Sarnat HB, Kakulas BA. Myopathies associated with hypothyroidism: a review based upon 13 cases. Aust N Z J Med. 1988;18(6):799-806.

70. Fein HG, Rivlin RS. Anemia in thyroid diseases. Med Clin North Am. 1975;59(5):1133-45.

71. Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger P, Tabarin A. Homocysteine, hypothyroidism, and effect of thyroid hormone replacement. Thyroid. 1999;9(12):1163-6.

72. McDermott MT, Haugen BR, Lezotte DC, Seggelke S, Ridgway EC. Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients. Thyroid. 2001 Aug;11(8):757-64.

72a.Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout A. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med. Aug 8-22 2005;165(15):1714-1720.

72b.Appelhof BC, Fliers E, Wekking EM, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab. May 2005;90(5):2666-2674.

72c.Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V, Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med. Mar 15 2005;142(6):412-424.

72d.Saravanan P, Simmons DJ, Greenwood R, Peters TJ, Dayan CM. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab. Feb 2005;90(2):805-812.

72e.Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. Jul 2006;91(7):2592-2599.

73. Carr D, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf). 1988 Mar;28(3):325-33.

74. Prinz PN, Scanlan JM, Vitaliano PP, Moe KE, Borson S, Toivola B, Merriam GR, Larsen LH, Reed HL. Thyroid hormones: positive relationships with cognition in healthy, euthyroid older men. J Gerontol A Biol Sci Med Sci. 1999 Mar;54(3):M111-6.

75. Rahman Q, Haboubi NY, Hudson PR, Lee GS, Shah IU. The effect of thyroxine on small intestinal motility in the elderly. Clin Endocrinol (Oxf). 1991 Nov;35(5):443-6.

76. Ellyin FM, Kumar Y, Somberg JC. Hypothyroidism complicated by angina pectoris: therapeutic approaches. J Clin Pharmacol. 1992;32(9):843-7.

77. Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid. 2000;10(8):665-79.

78. Levine HD. Compromise therapy in the patient with angina pectoris and hypothyroidism. A clinical assessment. Am J Med. 1980 Sep;69(3):411-8.

79. Davis FB, LaMantia RS, Spaulding SW, Wehmann RE, Davis PJ. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism. Arch Intern Med. 1984;144(9):1752-4.

80. Kabadi UM. Optimal daily levothyroxine dose in primary hypothyroidism. Its relation to pretreatment thyroid hormone indexes. Arch Intern Med. 1989 Oct;149(10):2209-12.

81. Young RE, Jones SJ, Bewsher PD, Hedley AJ. Age and the daily dose of thyroxine replacement therapy for hypothyroidism. Age Ageing. 1984 Sep;13(5):293-303.

82. Rosenbaum RL, Barzel US. Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med. 1982 Jan;96(1):53-5.

83. Sawin CT, Herman T, Molitch ME, London MH, Kramer SM. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med. 1983 Aug;75(2):206-9.

84. Cunningham JJ, Barzel US. Lean body mass is a predictor of the daily requirement for thyroid hormone in older men and women. J Am Geriatr Soc. 1984 Mar;32(3):204-7.

85. Kabadi UM. Variability of L-thyroxine replacement dose in elderly patients with primary hypothyroidism. J Fam Pract. 1987 May;24(5):473-7.

86. Kabadi UM. Influence of age on optimal daily levothyroxine dosage in patients with primary hypothyroidism grouped according to etiology.South Med J. 1997 Sep;90(9):920-4.

87. Taylor J, Williams BO, Frater J, Stott DJ, Connell J. Twice-weekly dosing for thyroxine replacement in elderly patients with primary hypothyroidism. J Int Med Res. 1994 Sep-Oct;22(5):273-7.

88. Grebe SK, Cooke RR, Ford HC, et al. Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab. 1997;82(3):870-5.

89. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med. 1995;333(25):1688-94.

90. Singh N, Weisler SL, Hershman JM. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid. 2001 Oct;11(10):967-71.

91. Shakir KM, Chute JP, Aprill BS, Lazarus AA. Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism. South Med J. 1997 Jun;90(6):637-9.

92. Siraj ES, Gupta MK, Reddy SS. Raloxifene causing malabsorption of levothyroxine. Arch Intern Med. 2003;163(11):1367-70.

93. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001;344(23):1743-9.

94. Arafah BM. Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer.Ann Intern Med. 1994 Aug 15;121(4):247-51.

95. Blackshear JL, Schultz AL, Napier JS, Stuart DD. Thyroxine replacement requirements in hypothyroid patients receiving phenytoin. Ann Intern Med. 1983;99(3):341-2.

96. Isley WL. Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement L-thyroxine. Ann Intern Med. 1987;107(4):517-8.

97. Cavlieri RR, Sung LC, Becker CE. Effects of phenobarbital on thyroxine and triiodothyronine kinetics in Graves' disease. J Clin Endocrinol Metab. 1973;37(2):308-16.

98. Aronow WS. The heart and thyroid disease. Clin Geriatr Med. 1995;11(2):219-29.

99. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994 Nov 10;331(19):1249-52.

100. Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med. 1990 Aug 15;113(4):265-9.

101. Manciet G, Dartigues JF, Decamps A, Barberger-Gateau P, Letenneur L,Latapie MJ, Latapie JL. The PAQUID survey and correlates of subclinical hypothyroidism in elderly community residents in the southwest of France. Age Ageing. 1995 May;24(3):235-41.

102. Lindeman RD, Schade DS, LaRue A, Romero LJ, Liang HC, Baumgartner RN, Koehler KM, Garry PJ. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc. 1999 Jun;47(6):703-9.

103. Bemben DA, Hamm RM, Morgan L, Winn P, Davis A, Barton E. Thyroid disease in the elderly. Part 2. Predictability of subclinicalhypothyroidism. J Fam Pract. 1994 Jun;38(6):583-8.

103a. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. Dec 1 2004;292(21):2591-2599.

104. Drinka PJ, Nolten WE, Voeks SK, Langer EH. Follow-up of mild hypothyroidism in a nursing home. J Am Geriatr Soc. 1991 Mar;39(3):264-6.

105. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000 Feb 15;132(4):270-8.

106. Mya MM, Aronow WS. Increased prevalence of peripheral arterial disease in older men and women with subclinical hypothyroidism. J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):68-9.

106a.Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. Nov 28 2005;165(21):2460-2466.

106b.Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. Mar 1 2006;295(9):1033-1041.

107. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med. 1984 Jul;101(1):18-24.

108. Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf). 1988 Jul;29(1):63-75.

109. Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arch Intern Med. 1990 Oct;150(10):2097-100.

110. Monzani F, Del Guerra P, Caraccio N, Pruneti CA, Pucci E, Luisi M,Baschieri L. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig. 1993 May;71(5):367-71.

111. Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, Harper S, Griffith L, Carbotte R. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med. 1996 Dec;11(12):744-9.

112. Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000;85(9):2993-3001.

113. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Jama. 2004;291(2):228-38.

114. Braverman LE. Subclinical hypothyroidism and hyperthyroidism in elderly subjects: should they be treated? J Endocrinol Invest. 1999;22(10 Suppl):1-3.

115. McConahey WM. Diagnosing and treating myxedema and myxedema coma. Geriatrics. 1978 Mar;33(3):61-6.

116. Bastenie PA, Bonnyns M, Vanhaelst L. Natural history of primary myxedema. Am J Med. 1985;79(1):91-100.

117. Hylander B, Rosenqvist U. Treatment of myxoedema coma--factors associated with fatal outcome. Acta Endocrinol (Copenh). 1985;108(1):65-71.

118. Nicoloff JT, LoPresti JS. Myxedema coma. A form of decompensated hypothyroidism. Endocrinol Metab Clin North Am. 1993;22(2):279-90.

119. Jordan RM. Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am. 1995;79(1):185-94.

120. Yamamoto T, Fukuyama J, Fujiyoshi A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid 1999 9(12): 1167-74.

121. Kaptein EM, Quion-Verde H, Swinney RS, Egodage PM, Massry SG. Acute hemodynamic effects of levothyroxine loading in critically ill hypothyroid patients. Arch Intern Med. 1986 Apr;146(4):662-6.

122. Ladenson PW, Goldenheim PD, Cooper DS, Miller MA, Ridgway EC. Early peripheral responses to intravenous L-thyroxine in primary hypothyroidism. Am J Med 1982;73(4):467-74.

123. Bulpitt CJ, Benos AS, Nicholl CG, Fletcher AE. Should medical screening of the elderly population be promoted? Gerontology. 1990;36(4):230-45.

124. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels GH, Cohen HD. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000 Jun 12;160(11):1573-5.

125. Drinka PJ, Nolten WE. Subclinical hypothyroidism in the elderly: to treat or not to treat? Am J Med Sci. 1988;295(2):125-8.

126. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med. 1990;112(11):840-9.

127. Belin RM, Ladenson PW, Robinson KA, Powe NR. Development and use of evidence-based clinical practice guidelines for thyroid disease. Endocrinol Metab Clin North Am 2002;31(3):795-817.

128. Clinical guideline, part 1. Screening for thyroid disease. American College of Physicians. Ann Intern Med. 1998 Jul 15;129(2):141-3.

129. Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians. Ann Intern Med. 1998 Jul 15;129(2):144-58.

130. Screening for thyroid disease: recommendation statement. Ann Intern Med. 2004;140(2):125-7.

131. Ressel G. Introduction to AAFP Summary of Recommendations for Periodic Health Examinations. American Academy of Family Physicians. Am Fam Physician. 2002 Apr 1;65(7):1467.

132. U.S. Preventive Services Task Force. Screening for thyroid disease: recommendation statement. Ann Intern Med. 2004 Jan 20;140(2):125-7.

133. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ. 2003 Aug 5;169(3):207-8.

134. Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA. 1996 Jul 24-31;276(4):285-92.

135. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Assessment of a screening process to detect patients aged 60 years and over at high risk of hypothyroidism. Br J Gen Pract. 1991 Oct;41(351):414-6.

136. Larson EB, Reifler BV, Sumi SM, Canfield CG, Chinn NM. Diagnostic evaluation of 200 elderly outpatients with suspected dementia. J Gerontol. 1985 Sep;40(5):536-43.

137. Cunha UG. An investigation of dementia among elderly outpatients. Acta Psychiatr Scand. 1990 Sep;82(3):261-3.

138. Jones TH, Hunter SM, Price A, Angelini GD. Should thyroid function be assessed before cardiopulmonary bypass operations? Ann Thorac Surg. 1994 Aug;58(2):434-6.